Similarly, epigenetic silencing of the DNA repair enzyme MGMT by promoter hypermethylation is present in a minority of cases of glioblastoma (~ 35%) and is associated with both improved survival and favorable response to the first line DNA-alkylating chemotherapy agent temozolomide10,12,13. Here, MGMT is linked to glioblastoma.